Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New perspectives on developing acute stroke therapy.

Marc Fisher1, Rajiv Ratan

  • 1Department of Neurology, University of Massachusetts Medical School, Worcester 01605, USA. fisherm@ummhc.org

Annals of Neurology
|January 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Fibrinogen on Tenecteplase Treatment in Acute Ischaemic Stroke After 4.5 Hours of Symptom Onset: A Post Hoc Analysis of the TRACE-III Trial.

Neurology and therapy·2026
Same author

Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours: The TNK-PLUS Randomized Clinical Trial.

JAMA·2026
Same author

RNS60 RESCUE Trial in Acute Ischemic Stroke: Post Hoc Analysis in Participants Enrolled <12 Hours Since Last Known Well.

Stroke (Hoboken, N.J.)·2026
Same author

Infarct growth rate and tenecteplase benefit in ischemic stroke at 4.5 to 24 h without thrombectomy-A secondary analysis of the TRACE-III randomized trial.

International journal of stroke : official journal of the International Stroke Society·2026
Same author

Antithrombotic strategies for the secondary prevention of stroke: A review.

The American journal of medicine·2026
Same author

Cytoprotection Concepts for Ischemic Stroke in the Recanalization Era.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

AQP4 and MOG Characterize the Autoantibody Landscape of Checkpoint Blockade-Induced Optic Neuritis.

Annals of neurology·2026
Same journal

Five Issues of Artificial Intelligence in Science: Sailing the Ship of Theseus.

Annals of neurology·2026
Same journal

Reply to "Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm".

Annals of neurology·2026
Same journal

Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm.

Annals of neurology·2026
Same journal

Imaging of Neurovascular Compression in Thoracic Outlet Syndrome.

Annals of neurology·2026
Same journal

Reply to "Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease".

Annals of neurology·2026
See all related articles

Developing new acute stroke therapies is crucial. Research into the ischemic penumbra, advanced imaging, and adaptive biological mechanisms offers hope for improved patient outcomes.

Area of Science:

  • Neuroscience
  • Cerebrovascular Medicine
  • Emergency Medicine

Background:

  • Intravenous recombinant tissue-type plasminogen activator is a primary acute stroke therapy, but its efficacy is limited to the first 3 hours.
  • Identifying the ischemic penumbra, or salvageable brain tissue, is key for targeted acute stroke therapies.
  • Advances in neuroimaging, such as MRI and CT, aid in identifying the ischemic penumbra.

Purpose of the Study:

  • To explore the need for additional acute stroke therapies beyond current treatments.
  • To review the role of the ischemic penumbra and imaging in guiding acute stroke interventions.
  • To discuss novel therapeutic strategies based on biological adaptive mechanisms and lessons from past clinical trials.

Main Methods:

  • Literature review and synthesis of current research on acute stroke therapies.

Related Experiment Videos

  • Analysis of the role of neuroimaging in identifying target tissues for intervention.
  • Examination of biological mechanisms like ischemic preconditioning and hibernation for therapeutic insights.

    • Main Results:

    • The ischemic penumbra is a critical target for acute stroke therapies.
    • Advanced imaging techniques show promise in identifying potentially salvageable brain tissue.
    • Understanding cellular injury and adaptive mechanisms informs new treatment development.

    Conclusions:

    • Further research into acute stroke therapies is essential to complement existing treatments.
    • Integrating knowledge of the ischemic penumbra, imaging, and biology can lead to more effective stroke interventions.
    • Optimizing acute stroke therapies aims to maximize functional recovery for a larger patient population.